Sumitomo Mitsui Trust Group
IOVA icon

Sumitomo Mitsui Trust Group’s Iovance Biotherapeutics IOVA Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,490,600
Closed -$17.5M – 1152
2023
Q2 		$17.5M Sell
2,490,600
-82,491
-3% -$590K 0.01% 732
2023
Q1 		$15.7M Sell
2,573,091
-14,527
-0.6% -$100K 0.01% 745
2022
Q4 		$16.5M Sell
2,587,618
-111,795
-4% -$873K 0.01% 741
2022
Q3 		$25.9M Sell
2,699,413
-100,229
-4% -$1.16M 0.02% 664
2022
Q2 		$30.9M Buy
2,799,642
+421,306
+18% +$5.52M 0.02% 642
2022
Q1 		$39.6M Sell
2,378,336
-2,586,760
-52% -$40M 0.03% 599
2021
Q4 		$94.8M Sell
4,965,096
-1,415,707
-22% -$31.2M 0.06% 356
2021
Q3 		$157M Sell
6,380,803
-1,356,815
-18% -$32M 0.1% 225
2021
Q2 		$201M Buy
7,737,618
+2,434,885
+46% +$63.3M 0.12% 191
2021
Q1 		$168M Buy
5,302,733
+878,823
+20% +$36.4M 0.1% 217
2020
Q4 		$205M Buy
4,423,910
+904,165
+26% +$35.9M 0.13% 176
2020
Q3 		$116M Buy
3,519,745
+759,199
+28% +$23.3M 0.08% 271
2020
Q2 		$75.8M Buy
2,760,546
+1,640,024
+146% +$53.9M 0.05% 378
2020
Q1 		$33.5M Sell
1,120,522
-205,987
-16% -$5.46M 0.03% 546
2019
Q4 		$36.7M Sell
1,326,509
-29,793
-2% -$678K 0.03% 566
2019
Q3 		$24.7M Buy
1,356,302
+92,206
+7% +$2.04M 0.02% 619
2019
Q2 		$31M Buy
1,264,096
+809,398
+178% +$12.2M 0.03% 578
2019
Q1 		$4.32M Buy
+454,698
New +$4.42M ﹤0.01% 732

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group's IOVA Position: Q3 2023 in Review

Sumitomo Mitsui Trust Group sold out of Iovance Biotherapeutics (IOVA) in Q3 2023, closing a stake of 2,490,600 shares — an estimated $17.5M sold.

Sumitomo Mitsui Trust Group first reported a position in IOVA in Q1 2019 and held it in 18 quarters. The position peaked at $205M in Q4 2020. 227 funds tracked by Wall St. Rank hold IOVA as of Q3 2023.

  • Sumitomo Mitsui Trust Group reported no remaining Iovance Biotherapeutics position as of Q3 2023 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 2,490,600 Iovance Biotherapeutics shares in Q3 2023, an estimated $17.5M.
  • Sumitomo Mitsui Trust Group first reported a position in Iovance Biotherapeutics in Q1 2019 and held it in 18 quarters.
  • Sumitomo Mitsui Trust Group's Iovance Biotherapeutics position peaked at $205M in Q4 2020.
  • 227 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2023.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2023, filed 30 Oct 2023.